Trial Profile
Evaluation of the Effect of Momelotinib on the Qt/Qtc Interval in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Sep 2015
Price :
$35
*
At a glance
- Drugs Momelotinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 10 Sep 2015 New trial record